Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation
- 1 December 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 77, 105971
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81200623, 81873558)
This publication has 52 references indexed in Scilit:
- Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic ApproachesGastroenterology, 2017
- Regulatory immune cells in regulation of intestinal inflammatory response to microbiotaMucosal Immunology, 2015
- Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Ulcerative colitisThe Lancet, 2012
- Crohn's diseaseThe Lancet, 2012
- FOXP3+ regulatory T cells in the human immune systemNature Reviews Immunology, 2010
- CD4 T-cell differentiation and inflammatory bowel diseaseTrends in Molecular Medicine, 2009
- Estrogen Receptors: How Do They Signal and What Are Their TargetsPhysiological Reviews, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Estrogen receptors and human diseaseJournal of Clinical Investigation, 2006